Asymptomatic neurocognitive disorders in patients infected by HIV: Fact or fiction?

40Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Neurocognitive disorders are emerging as a possible complication in patients infected with HIV. Even if asymptomatic, neurocognitive abnormalities are frequently detected using a battery of tests. This supported the creation of asymptomatic neurocognitive impairment (ANI) as a new entity. In a recent article published in BMC Infectious Diseases, Magnus Gisslén and colleagues applied a statistical approach, concluding that there is an overestimation of the actual problem. In fact, about 20% of patients are classified as neurocognitively impaired without a clear impact on daily activities. In the present commentary, we discuss the clinical implications of their findings. Although a cautious approach would indicate a stricter follow-up of patients affected by this disorder, it is premature to consider it as a proper disease. Based on a review of the data in the current literature we conclude that it is urgent to conduct more studies to estimate the overall risk of progression of the asymptomatic neurocognitive impairment. Moreover, it is important to understand whether new biomarkers or neuroimaging tools can help to identify better the most at risk population.Please see related article: http://www.biomedcentral.com/1471-2334/11/356. © 2011 Torti et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Torti, C., Focà, E., Cesana, B. M., & Lescure, F. X. (2011, October 28). Asymptomatic neurocognitive disorders in patients infected by HIV: Fact or fiction? BMC Medicine. https://doi.org/10.1186/1741-7015-9-138

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free